Logo image of VEON

VEON LTD (VEON) Stock Fundamental Analysis

USA - NASDAQ:VEON - US91822M5022 - ADR

52.65 USD
-2.3 (-4.19%)
Last: 10/17/2025, 3:15:46 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to VEON. VEON was compared to 22 industry peers in the Wireless Telecommunication Services industry. VEON scores excellent on profitability, but there are concerns on its financial health. VEON may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year VEON was profitable.
VEON had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VEON reported negative net income in multiple years.
In the past 5 years VEON always reported a positive cash flow from operatings.
VEON Yearly Net Income VS EBIT VS OCF VS FCFVEON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B

1.2 Ratios

VEON has a Return On Assets of 11.63%. This is amongst the best in the industry. VEON outperforms 100.00% of its industry peers.
With an excellent Return On Equity value of 75.34%, VEON belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Invested Capital of VEON (13.11%) is better than 100.00% of its industry peers.
VEON had an Average Return On Invested Capital over the past 3 years of 11.44%. This is significantly above the industry average of 5.84%.
The 3 year average ROIC (11.44%) for VEON is below the current ROIC(13.11%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.63%
ROE 75.34%
ROIC 13.11%
ROA(3y)-8.89%
ROA(5y)-4.97%
ROE(3y)-96.72%
ROE(5y)-77.85%
ROIC(3y)11.44%
ROIC(5y)10.01%
VEON Yearly ROA, ROE, ROICVEON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

VEON has a Profit Margin of 23.72%. This is amongst the best in the industry. VEON outperforms 100.00% of its industry peers.
VEON's Profit Margin has improved in the last couple of years.
VEON has a Operating Margin of 25.22%. This is amongst the best in the industry. VEON outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of VEON has remained more or less at the same level.
Looking at the Gross Margin, with a value of 87.75%, VEON belongs to the top of the industry, outperforming 95.45% of the companies in the same industry.
VEON's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 25.22%
PM (TTM) 23.72%
GM 87.75%
OM growth 3Y-3.83%
OM growth 5Y-0.35%
PM growth 3Y-16.1%
PM growth 5Y8.09%
GM growth 3Y-0.11%
GM growth 5Y2.49%
VEON Yearly Profit, Operating, Gross MarginsVEON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

3

2. Health

2.1 Basic Checks

VEON has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
VEON has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VEON has more shares outstanding
The debt/assets ratio for VEON has been reduced compared to a year ago.
VEON Yearly Shares OutstandingVEON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VEON Yearly Total Debt VS Total AssetsVEON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

VEON has an Altman-Z score of 0.36. This is a bad value and indicates that VEON is not financially healthy and even has some risk of bankruptcy.
VEON has a worse Altman-Z score (0.36) than 72.73% of its industry peers.
The Debt to FCF ratio of VEON is 3.88, which is a good value as it means it would take VEON, 3.88 years of fcf income to pay off all of its debts.
VEON's Debt to FCF ratio of 3.88 is amongst the best of the industry. VEON outperforms 86.36% of its industry peers.
A Debt/Equity ratio of 2.95 is on the high side and indicates that VEON has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.95, VEON is doing worse than 77.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.95
Debt/FCF 3.88
Altman-Z 0.36
ROIC/WACC1.43
WACC9.14%
VEON Yearly LT Debt VS Equity VS FCFVEON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.86 indicates that VEON may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.86, VEON is doing worse than 81.82% of the companies in the same industry.
VEON has a Quick Ratio of 0.86. This is a bad value and indicates that VEON is not financially healthy enough and could expect problems in meeting its short term obligations.
VEON has a Quick ratio of 0.85. This is in the lower half of the industry: VEON underperforms 77.27% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.85
VEON Yearly Current Assets VS Current LiabilitesVEON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

VEON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 133.93%, which is quite impressive.
Measured over the past years, VEON shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.57% on average per year.
Looking at the last year, VEON shows a small growth in Revenue. The Revenue has grown by 7.27% in the last year.
The Revenue for VEON have been decreasing by -14.69% on average. This is quite bad
EPS 1Y (TTM)133.93%
EPS 3Y-15.41%
EPS 5Y-8.57%
EPS Q2Q%750%
Revenue 1Y (TTM)7.27%
Revenue growth 3Y1.32%
Revenue growth 5Y-14.69%
Sales Q2Q%5.84%

3.2 Future

VEON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.05% yearly.
Based on estimates for the next years, VEON will show a small growth in Revenue. The Revenue will grow by 6.52% on average per year.
EPS Next Y37.27%
EPS Next 2Y21.27%
EPS Next 3Y19.72%
EPS Next 5Y13.05%
Revenue Next Year8.63%
Revenue Next 2Y8.08%
Revenue Next 3Y7.17%
Revenue Next 5Y6.52%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VEON Yearly Revenue VS EstimatesVEON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
VEON Yearly EPS VS EstimatesVEON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

VEON is valuated reasonably with a Price/Earnings ratio of 8.63.
Based on the Price/Earnings ratio, VEON is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
VEON is valuated cheaply when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
VEON is valuated cheaply with a Price/Forward Earnings ratio of 6.87.
Based on the Price/Forward Earnings ratio, VEON is valued cheaper than 90.91% of the companies in the same industry.
VEON's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.85.
Industry RankSector Rank
PE 8.63
Fwd PE 6.87
VEON Price Earnings VS Forward Price EarningsVEON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, VEON is valued cheaply inside the industry as 95.45% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.94
EV/EBITDA N/A
VEON Per share dataVEON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

VEON's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of VEON may justify a higher PE ratio.
A more expensive valuation may be justified as VEON's earnings are expected to grow with 19.72% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y21.27%
EPS Next 3Y19.72%

0

5. Dividend

5.1 Amount

No dividends for VEON!.
Industry RankSector Rank
Dividend Yield N/A

VEON LTD

NASDAQ:VEON (10/17/2025, 3:15:46 PM)

52.65

-2.3 (-4.19%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-13 2025-11-13
Inst Owners25.53%
Inst Owner Change0%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap3.72B
Analysts82.5
Price Target65.93 (25.22%)
Short Float %0.32%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.54%
Min EPS beat(2)-21.57%
Max EPS beat(2)60.64%
EPS beat(4)2
Avg EPS beat(4)15.89%
Min EPS beat(4)-21.57%
Max EPS beat(4)60.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.55%
Min Revenue beat(2)0.98%
Max Revenue beat(2)4.12%
Revenue beat(4)2
Avg Revenue beat(4)0.29%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)4.12%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)13.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.4%
EPS NY rev (1m)31.68%
EPS NY rev (3m)40.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.86%
Valuation
Industry RankSector Rank
PE 8.63
Fwd PE 6.87
P/S 0.9
P/FCF 2.94
P/OCF 3.01
P/B 2.85
P/tB N/A
EV/EBITDA N/A
EPS(TTM)6.1
EY11.59%
EPS(NY)7.66
Fwd EY14.55%
FCF(TTM)17.93
FCFY34.06%
OCF(TTM)17.47
OCFY33.17%
SpS58.71
BVpS18.48
TBVpS-3.5
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.63%
ROE 75.34%
ROCE 19.12%
ROIC 13.11%
ROICexc 19.47%
ROICexgc 33.65%
OM 25.22%
PM (TTM) 23.72%
GM 87.75%
FCFM 30.54%
ROA(3y)-8.89%
ROA(5y)-4.97%
ROE(3y)-96.72%
ROE(5y)-77.85%
ROIC(3y)11.44%
ROIC(5y)10.01%
ROICexc(3y)19.88%
ROICexc(5y)15.79%
ROICexgc(3y)51.88%
ROICexgc(5y)38.09%
ROCE(3y)16.68%
ROCE(5y)14.59%
ROICexcg growth 3Y65.7%
ROICexcg growth 5Y3.7%
ROICexc growth 3Y46.24%
ROICexc growth 5Y7.89%
OM growth 3Y-3.83%
OM growth 5Y-0.35%
PM growth 3Y-16.1%
PM growth 5Y8.09%
GM growth 3Y-0.11%
GM growth 5Y2.49%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 2.95
Debt/FCF 3.88
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 128.76%
Current Ratio 0.86
Quick Ratio 0.85
Altman-Z 0.36
F-Score5
WACC9.14%
ROIC/WACC1.43
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)133.93%
EPS 3Y-15.41%
EPS 5Y-8.57%
EPS Q2Q%750%
EPS Next Y37.27%
EPS Next 2Y21.27%
EPS Next 3Y19.72%
EPS Next 5Y13.05%
Revenue 1Y (TTM)7.27%
Revenue growth 3Y1.32%
Revenue growth 5Y-14.69%
Sales Q2Q%5.84%
Revenue Next Year8.63%
Revenue Next 2Y8.08%
Revenue Next 3Y7.17%
Revenue Next 5Y6.52%
EBIT growth 1Y13.2%
EBIT growth 3Y-2.56%
EBIT growth 5Y-14.99%
EBIT Next Year77.19%
EBIT Next 3Y27.84%
EBIT Next 5Y19.09%
FCF growth 1Y-32.93%
FCF growth 3Y-13.93%
FCF growth 5Y-2.16%
OCF growth 1Y-40.82%
OCF growth 3Y-24.51%
OCF growth 5Y-17.38%